Get the Stockscreener App
1.88
8.29%
-0.17
After Hours:
1.97
0.09
+4.79%
Cibus Inc stock is traded at $1.88, with a volume of 298.18K.
It is down -8.29% in the last 24 hours and down -23.89% over the past month.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
See More
Previous Close:
$2.05
Open:
$2.11
24h Volume:
298.18K
Relative Volume:
1.80
Market Cap:
$63.44M
Revenue:
$1.82M
Net Income/Loss:
$-267.63M
P/E Ratio:
-0.0932
EPS:
-20.1639
Net Cash Flow:
$-50.53M
1W Performance:
-2.08%
1M Performance:
-23.89%
6M Performance:
-69.33%
1Y Performance:
-89.55%
1-Day Range:
$1.84
$2.3057
1-Week Range:
$1.8036
$2.3057
52-Week Range:
$1.8036
$23.18
Cibus Inc Stock (CBUS) Company Profile
Name
Cibus Inc
Sector
Industry
Phone
(858) 450-0008
Address
6455 NANCY RIDGE DRIVE, SAN DIEGO
Compare CBUS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
1.88 | 63.44M | 1.82M | -267.63M | -50.53M | -20.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.31 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
684.87 | 75.07B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
622.61 | 37.96B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
243.53 | 31.79B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
111.56 | 27.34B | 3.30B | -501.07M | 1.03B | -2.1146 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-24 | Initiated | Alliance Global Partners | Buy |
| Jul-19-24 | Resumed | Canaccord Genuity | Buy |
| Oct-09-23 | Initiated | H.C. Wainwright | Buy |
| Jul-19-23 | Resumed | Canaccord Genuity | Buy |
Cibus Inc Stock (CBUS) Latest News
Cibus Announces Leadership Transition and CEO Succession Plan - Seed World
Cibus, Inc. Announces CEO Changes -February 28, 2025 at 08:30 am EST - Marketscreener.com
Cibus Appoints Peter Beetham as Interim CEO - TipRanks
Cibus Announces Leadership Change and CEO Succession Plan - The Manila Times
Who's Taking the Helm at Cibus? Inside the Leadership Shakeup During Critical Commercialization Phase - StockTitan
Cibus director Gerhard Prante sells $2,208 in stock By Investing.com - Investing.com Australia
Levi & Korsinsky Announces an Investigation on Behalf of Cibus, Inc. (CBUS) Shareholders Who May Have Been Affected by Fraud - ACCESS Newswire
Cibus director Gerhard Prante sells $2,208 in stock - Investing.com India
Cibus director Gerhard Prante sells $2,380 in stock - Investing.com India
Cibus director Gerhard Prante sells $2,380 in stock By Investing.com - Investing.com Australia
Cibus director Gerhard Prante sells $2,530 in stock By Investing.com - Investing.com South Africa
Cibus director Gerhard Prante sells $2,530 in stock - Investing.com India
Cibus director Gerhard Prante sells $2,702 in stock By Investing.com - Investing.com Australia
Cibus director Gerhard Prante sells $2,702 in stock - Investing.com India
Cibus director Gerhard Prante sells $2,967 of stock By Investing.com - Investing.com Nigeria
Cibus, Inc. (NASDAQ:CBUS) Short Interest Update - MarketBeat
Cibus director Gerhard Prante sells $2,967 of stock - Investing.com
Cibus, Inc. (NASDAQ:CBUS) Sees Large Decline in Short Interest - Defense World
Cibus director Prante sells $2,875 in stock By Investing.com - Investing.com Nigeria
Cibus director Gerhard Prante sells $2,990 in stock By Investing.com - Investing.com Nigeria
Cibus director Gerhard Prante sells $2,990 in stock - Investing.com
Cibus director Prante Gerhard sells $2,875 in stock - MSN
Cibus director Gerhard Prante sells $2,909 in stock - MSN
Cibus director Gerhard Prante sells $2,909 in stock By Investing.com - Investing.com Australia
Cibus director Gerhard Prante sells $2,817 in stock - MSN
Cibus director Prante sells $2,875 in stock - MSN
Cibus Announces Important Update to Rice Gene Editing Conversion Rates - The Manila Times
Cibus, Inc. Issues Correction on Rice Gene Editing Conversion Rates and Updates on Technological Advances - Nasdaq
Research Setback: Cibus Unable to Replicate Promising Gene Editing Results in Rice - StockTitan
Cibus director Gerhard Prante sells $5,531 in stock - MSN
Cibus director Gerhard Prante sells $2,817 in stock By Investing.com - Investing.com Australia
Cibus director Prante Gerhard sells $2,898 in stock - MSN
Cibus’ $22.6 Million Common Stock Offering - Global Legal Chronicle
Cibus director Gerhard Prante sells shares worth $2,852 By Investing.com - Investing.com Australia
Cibus director Gerhard Prante sells shares worth $2,852 - Investing.com
Cibus director Prante Gerhard sells $2,898 in stock By Investing.com - Investing.com Australia
Cibus Inc Stock (CBUS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cibus Inc Stock (CBUS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Prante Gerhard | Director |
Feb 24 '25 |
Sale |
2.07 |
1,150 |
2,380 |
8,857 |
| Prante Gerhard | Director |
Feb 21 '25 |
Sale |
2.20 |
1,150 |
2,530 |
10,007 |
| Prante Gerhard | Director |
Feb 20 '25 |
Sale |
2.35 |
1,150 |
2,702 |
11,157 |
| Prante Gerhard | Director |
Feb 19 '25 |
Sale |
2.58 |
1,150 |
2,967 |
12,307 |
| Prante Gerhard | Director |
Feb 18 '25 |
Sale |
2.52 |
2,300 |
5,796 |
13,457 |
| Prante Gerhard | Director |
Feb 14 '25 |
Sale |
2.60 |
1,150 |
2,990 |
15,757 |
| Prante Gerhard | Director |
Feb 13 '25 |
Sale |
2.53 |
1,150 |
2,910 |
16,907 |
| Prante Gerhard | Director |
Feb 12 '25 |
Sale |
2.45 |
1,150 |
2,818 |
18,057 |
| Prante Gerhard | Director |
Feb 11 '25 |
Sale |
2.48 |
1,150 |
2,852 |
19,207 |
| Prante Gerhard | Director |
Feb 10 '25 |
Sale |
2.52 |
1,150 |
2,898 |
20,357 |
6.45%
1.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):